As part of the process of exploring new bioactive components from K. galanga, the six isolates were then tested for their effects on NFκB gene activity and cell viability for B16F10 melanoma skin cancer cells, using the luciferin/luciferase reporter assay/WST-8 method. The gene discussed is NFKB1; the disease is melanoma.